CAPP Medical Overview
- Founded
-
2013
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
CAPP Medical General Information
Description
Developer of technology for cancer screening and monitoring through the detection of circulating tumor DNA in blood. The company develops disruptive liquid non-invasive cancer detection technology using next generation DNA sequencing. Its technology allows for sensitivity and specificity without the need for patient specific optimizations.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- Palo Alto, CA
- United States
CAPP Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CAPP Medical Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Ashok Krishnamurthi | Chief Executive Officer |
CAPP Medical Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|